AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NUTRITIONAL GROWTH SOLUTIONS

0.023

-0.001-4.17%

Volume:2K

Turnover:48

Market Cap:7.66M

PE:-1.55

High:0.023

Open:0.023

Low:0.023

Close:0.024

52wk High:0.029

52wk Low:0.015

Shares:333.09M

Float Shares:107.93M

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.015

EPS(LYR):-0.010

ROE:-304.85%

ROA:-79.82%

PB:19.00

PE(LYR):-2.32

Loading ...

Overview Company News Filings

Nutritional Growth Solutions Receives Firm Commitments To Raise A$2.5 Million

Nutritional Growth Solutions Ltd - to Buy 100% of Sprout Organic Pty Ltd

THOMSON REUTERS

Nutritional Growth Solutions Ltd - Receives Firm Commitments to Raise a$2.5 Mln via Placement at a$0.02 per Share

THOMSON REUTERS

Nutritional Growth Solutions Ltd - Appoints Selasi Berdie as CEO and Executive Director on Completion

THOMSON REUTERS

Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan

BRIEF-Nutritional Growth Solutions Seeks Trading Halt

Nutritional Growth Solutions Ltd - Seeks Trading Halt Pending Announcement on Proposed Acquisition and Capital Raise

THOMSON REUTERS

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

Nutritional Growth Solutions Ltd-Non-Executive Director Resignation

THOMSON REUTERS

ACT Genomics ยกระดับการวิเคราะห์รหัสพันธุกรรมเชิงลึกซึ่งเป็นที่ยอมรับทางการแพทย์ด้วยแผงตรวจ 101 ยีน พร้อมระยะดำเนินการ 7 วัน

BRIEF-Nutritional Growth Solutions Says Manik Pujara Assumes Interim CEO And CFO Functions

Nutritional Growth Solutions Ltd - Manik Pujara Assumes Interim CEO and CFO Functions

THOMSON REUTERS

Nutritional Growth Solutions Ltd - Andrew Grover Steps Down as Interim CEO, Continues as Non-Executive Chair

THOMSON REUTERS

triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy

BRIEF-Nutritional Growth Solutions Says Andrew Grover Appointed As Chair

Nutritional Growth Solutions - Interim CEO Andrew Grover Appointed as Chair

THOMSON REUTERS

Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026

Nutritional Growth Solutions Ltd-Change of Local Agent

THOMSON REUTERS

Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.

BRIEF-Nutritional Growth Solutions Says Appointment Of Interim CEO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NGS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NGS.AU\",,,,,undefined,":{"symbol":"NGS.AU","market":"AU","secType":"STK","nameCN":"NUTRITIONAL GROWTH SOLUTIONS","latestPrice":0.023,"timestamp":1787292720000,"preClose":0.024,"halted":0,"volume":2100,"delay":0,"changeRate":-0.041666666666666706,"nameEN":"NUTRITIONAL GROWTH SOLUTIONS","floatShares":107925515,"shares":333093207,"eps":-0.014856,"marketStatus":"Market Closed","change":-0.001,"latestTime":"08-21 16:12:00 AEST","open":0.023,"high":0.023,"low":0.023,"amount":48,"amplitude":0,"askPrice":0.024,"askSize":220466,"bidPrice":0.023,"bidSize":247900,"shortable":3,"etf":0,"ttmEps":-0.014856,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.024,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.0010056190159490098,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NGS.AU","preClose":0.02,"auctionPrice":0.02,"auctionVolume":25000,"auction":3,"marketStatus":"盘后竞价","timestamp":1786946400976}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NGS.AU\",,,,,undefined,":{"symbol":"NGS.AU","floatShares":107925515,"roa":"-79.82%","roe":"-304.85%","lyrEps":-0.009909,"volumeRatio":0.0010056190159490098,"shares":333093207,"dividePrice":0,"high":0.023,"amplitude":0,"preClose":0.024,"low":0.023,"week52Low":0.015,"pbRate":"19.00","psRate":"3.37","week52High":0.029,"institutionHeld":0,"latestPrice":0.023,"committee":0.058574,"eps":-0.014856,"divideRate":0,"volume":2100,"delay":0,"ttmEps":-0.014856,"open":0.023,"prevYearClose":0.022,"prevWeekClose":0.02,"prevMonthClose":0.022,"prevQuarterClose":0.021,"fiveDayClose":0.02,"twentyDayClose":0.022,"sixtyDayClose":0.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGS.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-07-25","symbol":"NGS.AU","defaultRemindTime":1721865600000,"type":"split","dateTimestamp":1721829600000,"forFactor":10,"toFactor":1,"ratio":10},{"date":"2022-07-28","symbol":"NGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1658966400000,"name":null,"time":"","dateTimestamp":1658930400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638980589","title":"Nutritional Growth Solutions Receives Firm Commitments To Raise A$2.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2638980589","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638980589?lang=en_us&edition=fundamental","pubTime":"2026-05-25 09:54","pubTimestamp":1779674099,"startTime":"0","endTime":"0","summary":"May 25 (Reuters) - Nutritional Growth Solutions Ltd ::*TRANSFORMATIONAL ACQUISITION*RECEIVES FIRM COMMITMENTS TO RAISE A$2.5 MILLION VIA PLACEMENT AT A$0.02 PER SHARE*TO BUY 100% OF SPROUT ORGANIC PTY","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nRSD1dYYSy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638859865","title":"Nutritional Growth Solutions Ltd - to Buy 100% of Sprout Organic Pty Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2638859865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638859865?lang=en_us&edition=fundamental","pubTime":"2026-05-25 08:25","pubTimestamp":1779668719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUE79G9KZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585989","title":"Nutritional Growth Solutions Ltd - Receives Firm Commitments to Raise a$2.5 Mln via Placement at a$0.02 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585989","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638585989?lang=en_us&edition=fundamental","pubTime":"2026-05-25 08:25","pubTimestamp":1779668719,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUE79G9KZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638458598","title":"Nutritional Growth Solutions Ltd - Appoints Selasi Berdie as CEO and Executive Director on Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2638458598","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638458598?lang=en_us&edition=fundamental","pubTime":"2026-05-25 08:25","pubTimestamp":1779668719,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUE79G9KZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637395296","title":"Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2637395296","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637395296?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:45","pubTimestamp":1779432300,"startTime":"0","endTime":"0","summary":"Satellite symposium and exhibition engagement highlighted strong physician interest in MRD, MCED, and evidence-driven adoption of genomic testing.TAIPEI, May 22, 2026 /PRNewswire/ -- Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference , marking its first major oncology conference presence in Taiwan.Scientific Program and Faculty HighlightsThe event brought together a distinguished faculty of Taiwan-based and regional experts to discuss the evolving role of liquid biopsy in precision oncology, with a focus on multi-omics, artificial intelligence, MRD, and MCED.Assistant Professor Aaron Tan Chia-Ken  delivered a pan-cancer perspective on the value of liquid biopsy and multi-omics across all stages of cancer care. He illustrated the broad clinical utility of liquid biopsy — from genotyping and treatment selection in advanced disease, ctDNA ","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2985328/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2985328/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-showcases-ai-powered-multi-omics-liquid-biopsy-innovations-at-tjcc-2026-advancing-precision-oncology-in-taiwan-302779916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","DNA","BK4543","NGS","TAT","BK4109","BK4121","NGS.AU","MRD.AU","TAT.AU","ARTY","AI","BK4585","BK7078","BK7111","DNA.AU","BK4587","AIPO","BK4139","AGIX","BK4023","AIYY","BK4588","BK4179","BK4551","BK7095","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637870154","title":"BRIEF-Nutritional Growth Solutions Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2637870154","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637870154?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:41","pubTimestamp":1779327718,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Seeks Trading HaltMay 21 (Reuters) - Nutritional Growth Solutions Ltd NGS.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PROPOSED ACQUISITION AND CAPITAL RAISEFurther company coverage: NGS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41X13Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637871465","title":"Nutritional Growth Solutions Ltd - Seeks Trading Halt Pending Announcement on Proposed Acquisition and Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2637871465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637871465?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:32","pubTimestamp":1779319954,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X13Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635741983","title":"Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA","url":"https://stock-news.laohu8.com/highlight/detail?id=2635741983","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635741983?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:58","pubTimestamp":1778774280,"startTime":"0","endTime":"0","summary":"Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level EvidenceNASHIK, India, May 14, 2026 /PRNewswire/ -- Datar Cancer Genetics , a global precision oncology company, today announced that its tissue-based comprehensive genomic profiling  assay for all solid tumors, CellDx-Tissue, has been cleared by the US Food and Drug Administration .The clearance strengthens DCG's position in delivering a breakthrough platform intended for use by oncologists globally to make personalised clinical management decisions in accordance with professional guidelines and complements the company's earlier US FDA Breakthrough Device Designations for its liquid biopsy platforms.","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2980273/Datar_Cancer_Genetics_US_FDA.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2980273/Datar_Cancer_Genetics_US_FDA.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/datar-cancer-genetics-receives-landmark-us-fda-clearance-for-celldx-tissue-a-comprehensive-genomic-profiling-assay-for-solid-tumors-using-dna--rna-302772619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","NGS","BK4109","DCG.AU","BK4139","BK4585","BK4588","BK4211","BK4121","BK4505","NGS.AU","BK7055","BK4179","BK7111","RNA","LARK","LABU","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633106042","title":"Nutritional Growth Solutions Ltd-Non-Executive Director Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2633106042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633106042?lang=en_us&edition=fundamental","pubTime":"2026-05-08 08:06","pubTimestamp":1778198805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUE49DJM1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628214792","title":"ACT Genomics ยกระดับการวิเคราะห์รหัสพันธุกรรมเชิงลึกซึ่งเป็นที่ยอมรับทางการแพทย์ด้วยแผงตรวจ 101 ยีน พร้อมระยะดำเนินการ 7 วัน","url":"https://stock-news.laohu8.com/highlight/detail?id=2628214792","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628214792?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:00","pubTimestamp":1776646800,"startTime":"0","endTime":"0","summary":"101 :      ACTDrug  ACT Genomics     ACTDrug Breast, ACTLung  ACTDrug GI    ACT Genomics  Delta Group  NGS ACTDrug  ACT Genomics   ACT Genomics     ACTDrug    ACT Genomics ACT GenomicsACT Genomics  Delta  ACT Genomics","market":"us","thumbnail":"https://mma.prnewswire.com/media/2945297/ACTDrug_Press_Visual.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2945297/ACTDrug_Press_Visual.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/act-genomics--101---7--302745790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4229","NGS","BK4195","ACT","BK4179","NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627593522","title":"BRIEF-Nutritional Growth Solutions Says Manik Pujara Assumes Interim CEO And CFO Functions","url":"https://stock-news.laohu8.com/highlight/detail?id=2627593522","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627593522?lang=en_us&edition=fundamental","pubTime":"2026-04-16 07:58","pubTimestamp":1776297509,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Says Manik Pujara Assumes Interim CEO And CFO FunctionsApril 16  - Nutritional Growth Solutions Ltd NGS.AX:MANIK PUJARA ASSUMES INTERIM CEO AND CFO FUNCTIONSANDREW GROVER STEPS DOWN AS INTERIM CEO, CONTINUES AS NON-EXECUTIVE CHAIRFurther company coverage: NGS.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0JE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627561122","title":"Nutritional Growth Solutions Ltd - Manik Pujara Assumes Interim CEO and CFO Functions","url":"https://stock-news.laohu8.com/highlight/detail?id=2627561122","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627561122?lang=en_us&edition=fundamental","pubTime":"2026-04-16 07:26","pubTimestamp":1776295571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0JE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627256114","title":"Nutritional Growth Solutions Ltd - Andrew Grover Steps Down as Interim CEO, Continues as Non-Executive Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2627256114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627256114?lang=en_us&edition=fundamental","pubTime":"2026-04-16 07:26","pubTimestamp":1776295571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0JE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627496473","title":"triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy","url":"https://stock-news.laohu8.com/highlight/detail?id=2627496473","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627496473?lang=en_us&edition=fundamental","pubTime":"2026-04-14 11:30","pubTimestamp":1776137400,"startTime":"0","endTime":"0","summary":"Dr. Tang Hung Sang, Medical Director of Gene Solutions, at the \"An Innovative Approach to Non-Invasive Prenatal Screening in Asia\" symposium. While traditional NIPT has long been the gold standard for detecting commontrisomies, Gene Solutions is challenging the status quo.Fetal chromosomal abnormalities, supported bymachinelearning modelsto help reduceno-callrates whenfetal fractionis low and toidentifymaternal sexchromosome abnormalities—thereby reducingfalse positives in screening forfetal sexchromosome aneuploidy.","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2954713/image_5022623_35790502.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2954713/image_5022623_35790502.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/trisure-nipt-debuts-in-taiwan-expanding-non-invasive-prenatal-screening-beyond-aneuploidy-302741143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BK4179","NPV","NGS","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621654080","title":"BRIEF-Nutritional Growth Solutions Says Andrew Grover Appointed As Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2621654080","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621654080?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:35","pubTimestamp":1774348546,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Says Andrew Grover Appointed As ChairMarch 24 (Reuters) - Nutritional Growth Solutions Ltd NGS.AX:INTERIM CEO ANDREW GROVER APPOINTED AS CHAIRFurther company coverage: NGS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C00R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621055524","title":"Nutritional Growth Solutions - Interim CEO Andrew Grover Appointed as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055524","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621055524?lang=en_us&edition=fundamental","pubTime":"2026-03-24 14:14","pubTimestamp":1774332882,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C00R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616304195","title":"Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2616304195","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616304195?lang=en_us&edition=fundamental","pubTime":"2026-03-04 10:00","pubTimestamp":1772589600,"startTime":"0","endTime":"0","summary":"From left to right: Prof. Dr. Taha Bahi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye; Prof. Dr. Mustafa zdoan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye; Dr. Le Son Tran, Principal Investigator at Gene Solutions; Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore and Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions.As hereditary cancer care evolves from risk assessment toward earlier detection, personalized surveillance, and preventive precision care, IHCC served as a key platform to discuss the clinical integration of genomic medicine and multidisciplinary models of care.In collaboration with ATC Genomics Salk Teknolojileri A.. , a leading Türkiye-based provider and distributor with over 30 years of experience in molecular diagnostics and life sciences—Gene Solutions presented compelling new Real-World Evidence  from one of the ","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2924710/image_5022623_22868733.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2924710/image_5022623_22868733.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-announces-strategic-entry-into-turkiye-with-robust-real-world-evidence-at-the-2nd-international-hereditary-cancers-congress-2026-302702530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","NGS","BK7111","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616375874","title":"Nutritional Growth Solutions Ltd-Change of Local Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2616375874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616375874?lang=en_us&edition=fundamental","pubTime":"2026-03-02 06:08","pubTimestamp":1772402919,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260301:nTUE7WYZ2Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605123766","title":"Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2605123766","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605123766?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:00","pubTimestamp":1768957200,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing  leader in validation platforms for Laboratory Developed Tests , announced a strategic collaboration to advance U.S. verification and clinical validation of liquid biopsy assays designed for cancer detection, profiling, and monitoring.From left to right: John Moore, CEO of Pangea Laboratory, and Keng-Hou Hsu, Chief Financial Officer of Gene Solutions. Under the agreement, Gene Solutions will provide SOPs, funding, and technical support from its CAP-accredited NGS laboratories in Singapore and Vietnam. Pangea Laboratory will oversee all analytical and clinical validation of Gene Solutions' tests at its U.S. facilities in Irvine, California. The collaboration is to streamline U.S. readiness for Gene Solutions' AI-powered multi-omics liquid biopsy technologies within CLIA/CAP quality systems.The first collaboration","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2865094/Pangea_Laboratory_Gene_Solutions_Teams.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2865094/Pangea_Laboratory_Gene_Solutions_Teams.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-and-pangea-laboratory-establish-strategic-collaboration-to-validate-laboratory-developed-ctdna-tests-for-precision-screening-and-cancer-care-in-the-us-302665551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRD.AU","BK7095","NGS.AU","BK7111","BK4179","NGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593472854","title":"BRIEF-Nutritional Growth Solutions Says Appointment Of Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2593472854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593472854?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:54","pubTimestamp":1766541296,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Says Appointment Of Interim CEODec 24  - Nutritional Growth Solutions Ltd NGS.AX:MD & CEO DEPARTURE AND APPOINTMENT OF INTERIM CEOSTEPHEN J. TURNER WILL DEPART FROM HIS ROLE AS CEO AND MANAGING DIRECTORANDREW GROVER APPOINTED AS INTERIM CEOFurther company coverage: NGS.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nTUE1XNBF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}